Recently, the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) 6 and Researching Cardiovascular Events with a Weekly Incretin in Diabetes trials have shown that therapy with glucagon-like peptide-1 receptor agonists (GLP-1RAs) decreases the risk of cardiovascular events in high-risk patients with T2DM [6, 7]
GLP-1 Injections: A Promising Approach to Reducing Alcohol Consumption In recent years, a groundbreaking development in the field of addiction treatment has emerged: the potential use of GLP-1 (Glucagon-Like Peptide-1) injections to help individuals drink less alcohol
Beyond BPC 157: General Rules for Traveling with Research Compounds The principles we've outlined for BPC 157 apply to a wide range of other research peptides
Fifteen-point mutation types have been identified in human MTHFR, the most common and important of which is the mutation in C677T , which manifests itself in three genotypes, CC, CT, and TT
Was identity confirmed by LC-MS